Notice: This company has been marked as potentially delisted and may not be actively trading. Silk Road Medical (SILK) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Get the Latest News and Ratings for SILK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Silk Road Medical and its competitors. Enter your email to sign up for newsletter Sign Up SILK Analyst Ratings Over TimeTypeCurrent Forecast12/5/23 to 12/4/241 Month Ago11/5/23 to 11/4/243 Months Ago9/6/23 to 9/5/241 Year Ago12/5/22 to 12/5/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)1 Buy rating(s)1 Buy rating(s)Hold4 Hold rating(s)4 Hold rating(s)7 Hold rating(s)7 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)2 Sell rating(s)2 Sell rating(s)Consensus Price Target$24.00$24.00$21.50$24.60Forecasted Upside-12.70% Downside-12.70% Downside-20.43% Downside159.77% UpsideConsensus RatingReduceReduceReduceReduce Even Trump can’t stop what’s coming. (Ad)No matter who sits in the White House over the next four years, a series of events has been triggered that could devastate millions of Americans. These events have caused five major cracks in our economy... That's why I have moved 7-figures of my own money out of the stock market.Watch my emergency briefing here >>> SILK Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History SILK Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Silk Road Medical Stock vs. The CompetitionTypeSilk Road MedicalMedical CompaniesS&P 500Consensus Rating Score 1.80 2.81 2.50Consensus RatingReduceModerate BuyModerate BuyPredicted Upside-12.70% Downside26,784.61% Upside7.37% UpsideNews Sentiment RatingNeutral NewsSee Recent SILK NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails7/17/2024Stifel Nicolaus4 of 5 stars Reiterated RatingBuy ➝ Hold$23.00 ➝ $27.50+1.59%7/11/2024Argus2 of 5 starsS. SilverSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Sell6/18/2024Lake Street Capital2 of 5 starsF. TakkinenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$28.00 ➝ $27.50+2.31%5/1/2024JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetNeutral ➝ Neutral$19.00 ➝ $21.00+9.78%5/1/2024Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetNeutral ➝ Neutral$18.00 ➝ $20.00+9.11%10/24/2023Wolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeUnderperform ➝ Peer Perform Get the Latest News and Ratings for SILK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. 10/11/2023CL KingSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Neutral10/11/2023CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Sell$35.00 ➝ $8.00-42.82%10/11/2023B. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingN. ChatterjiSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$54.00 ➝ $14.00+0.07%9/5/2023OppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$30.00+61.29%7/12/2023Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating DowngradeBuy ➝ Underperform$51.00 ➝ $28.00-14.24%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:47 AM ET. SILK Forecast - Frequently Asked Questions What is Silk Road Medical's forecast for 2025? According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Silk Road Medical is $24.00, with a high forecast of $27.50 and a low forecast of $20.00. Should I buy or sell Silk Road Medical stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There is currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" SILK shares. Does Silk Road Medical's stock price have much downside? According to analysts, Silk Road Medical's stock has a predicted downside of -12.70% based on their 12-month stock forecasts. Do Wall Street analysts like Silk Road Medical more than its competitors? Analysts like Silk Road Medical less than other "medical" companies. The consensus rating for Silk Road Medical is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SILK compares to other companies. Stock Forecasts and Research Tools Related Companies Envista Stock Forecast Axonics Stock Forecast NovoCure Stock Forecast Inari Medical Stock Forecast TransMedics Group Stock Forecast LivaNova Stock Forecast Enovis Stock Forecast iRhythm Technologies Stock Forecast CONMED Stock Forecast Warby Parker Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Even Trump can’t stop what’s coming. (Ad)No matter who sits in the White House over the next four years, a series of events has been triggered that could devastate millions of Americans. These events have caused five major cracks in our economy... That's why I have moved 7-figures of my own money out of the stock market.Watch my emergency briefing here >>> This page (NASDAQ:SILK) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredCoins Set to Soar with a Pro-Crypto White HouseCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredHas World War III already started?As global tensions are rising, so does the potential of direct conflict between the US and China. That's wh...Behind the Markets | SponsoredMeet the NYSE traded company behind a potentially blockbuster antiviral drugThis public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imag...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Silk Road Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
